This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Richard E. Brown, Jr, MD; Roland Sabates, MD; Sheila J. Drew, RN

Arch Ophthalmol. 1987;105(5):658-659.

Abstract
• Fluorescein angiography carries with it a variable incidence of nausea and vomiting. We investigated a method of prophylaxis against this side effect. One hundred patients undergoing fluorescein angiography were pretreated in a doublemasked, randomized fashion with either 20 mg of intravenous metoclopramide hydrochloride or an equal volume of normal saline soution. The metoclopramidetreated group demonstrated a statistically significant decrease in the incidence of nausea and vomiting. Eleven (22%) of the control group and three (6%) of the metoclopramide-treated group had this complication. Metoclopramide is an effective drug when used prophylactically in selected patients undergoing fluorescein angiography.

Author Affiliations
From the Department of Ophthalmology, Truman Medical Center, University of Missouri at Kansas City School of Medicine.

Footnotes
Accepted for publication Jan 30, 1987.

Reprint requests to Department of Ophthalmology, Truman Medical Center, University of Missouri at Kansas City School of Medicine, Kansas City, MO 64108 (Dr Sabates).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?